EltaMD Appears in 88.0% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending Sunscreen Brands. For more detail, you can also read Sunscreen Brands: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Related research
- Learn More
Key Takeaways
- EltaMD is present in most benchmark answers and is often placed first when it appears.
- The main opportunity is not tone, but verifying conflicting price and SPF claims against primary sources.
- Several cited third-party pages and EltaMD site pages should be reviewed before any edits or outreach are proposed.
- Buyer questions about best sunscreen, acne-prone skin, and facial use can guide new or refreshed content briefs.
Answer Capsule
In November 2026, EltaMD appeared in 324 of 368 AI answers included in the Sunscreen Brands benchmark (88.04%). It received 296 recommendations (80.43%), with 251 Top 3 placements and 147 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do EltaMD mentions, recommendations and placements compare with its Sunscreen Brands peers?
EltaMD recorded 324 mentions (88.04%) and 296 recommendations (80.43%) across 368 answers included in the benchmark. Top 3 placements numbered 251; first-place recommendations numbered 147. Framing among its mentions was 300 positive, 23 neutral and 1 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | La Roche-Posay | 353 | 95.92% | 313 | 85.05% | 241 | 65.49% | 60 | 16.30% |
2 | EltaMD | 324 | 88.04% | 296 | 80.43% | 251 | 68.21% | 147 | 39.95% |
3 | Supergoop | 278 | 75.54% | 248 | 67.39% | 131 | 35.60% | 40 | 10.87% |
4 | Neutrogena | 274 | 74.46% | 232 | 63.04% | 99 | 26.90% | 21 | 5.71% |
5 | CeraVe | 262 | 71.20% | 230 | 62.50% | 119 | 32.34% | 25 | 6.79% |
6 | Sun Bum | 89 | 24.18% | 62 | 16.85% | 13 | 3.53% | 4 | 1.09% |
7 | Cetaphil | 56 | 15.22% | 52 | 14.13% | 13 | 3.53% | 1 | 0.27% |
8 | Kopari Beauty | 1 | 0.27% | 1 | 0.27% | 0 | 0.00% | 0 | 0.00% |
9 | Vichy | 3 | 0.82% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
EltaMD appears in most benchmark answers and is endorsed in the large majority of them, which puts it in the leading group rather than on the fringe. Its distinctive strength is placement: when it shows up, it is often named first. That matters because buyers scanning a short list tend to weigh the top name most heavily.
The gap to the leader is narrow on mentions but wider on recommendations, so the practical question is not whether EltaMD is seen but whether answers consistently endorse it. We would build a scorecard that tracks mentions, endorsements and placement separately, so the client can see which lever is actually moving.
Framing is overwhelmingly positive, with very few neutral or negative mentions. That is a healthy base, but it also means further gains are unlikely to come from fixing tone. The more useful work is verifying the claims answers make and strengthening the pages and sources that answers draw on.
What changed since last month
Questions This Section Answers
- How did EltaMD counts and coverage differ across the available monthly snapshots?
Metric | Nov 2026 |
|---|---|
Mentions | 324 / 368 (88.04%) |
Recommendations | 296 / 368 (80.43%) |
Top 3 recommendations | 251 / 368 (68.21%) |
#1 recommendations | 147 / 368 (39.95%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.
This edition is the first built on the wider question set, so the figures describe a new baseline rather than a movement from earlier months. The earlier editions used a narrower set of questions and remain in the archive; they should not be read as a trend line against this month.
That distinction matters for how the client reads the numbers. A strong showing here says EltaMD is well represented across a broader range of questions than before, not that its position improved or slipped. We would treat this month as the reference point and compare future editions only once they use the same screening scope.
For planning, that means the first useful comparison arrives with the next edition on the same basis. Until then, the client should focus on the verification and content work rather than on month-to-month movement.
AI recommendation trend
Observed recommendation rate (%), Nov 2026
- EltaMDno changeNov 202680.43%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for EltaMD?
AI answers contained 12 conflicting claims about EltaMD: 0 critical, 4 high, 7 medium, 1 low. Of these, 4 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
The recorded answers contain a dozen conflicting claims about EltaMD, and a small group of them carry the highest severity ratings. Those ratings are a prioritization tool, not a finding that the company or any publisher got something wrong. They tell us where to look first.
We would pair the visibility comparison with a scoped fact-review list, so the client can see which claims are worth checking against current primary sources and in what order. Each item would get an owner, the evidence needed to settle it, and a status.
This keeps effort proportionate. Most claims will likely resolve as date or variant differences; a few may need a page or source update. Separating those outcomes early prevents the team from chasing every discrepancy as if it were an error.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about EltaMD should be verified before proposed page edits?
Review topic | Severity | Recorded AI claim A | Recorded AI claim B |
|---|---|---|---|
UV Sport SPF 50 price | high | $26.64 (sale) / $37 regular | $61.00 |
product line / SPF of recommended body sunscreen | low | UV Sport SPF 50 | UV Pure Broad-Spectrum SPF 47 |
SPF level of UV Daily | medium | SPF 50 | SPF 40 |
UV Clear SPF 46 price | high | $18.80 | $46.00 |
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
The disputed topics cluster around price and SPF labeling for specific products, including the UV Clear and UV Sport lines and the UV Daily SPF level. Both recorded claims are quoted from AI answers, so neither column is a verified fact. Different dates, sale pricing or product variants could account for an apparent conflict.
We would not decide which claim is true from the report alone. Instead, the proposed work is to confirm the current product name, size, price and SPF against the company's own live pages and authorized retail listings, then record the verified position with its date.
Only after that check would we draft conditional page briefs. Where the site already states the correct information clearly, the brief may be a small clarification; where it does not, the brief would set out the approved facts and where they should appear.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for EltaMD?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://glamour.com/gallery/best-sunscreen-for-acne-prone-skin | 11 | 11 | 4 |
https://aad.org/public/everyday-care/sun-protection/shade-clothing-sunscreen/choosing-right-sunscreen | 20 | 16 | 3 |
https://dermskincare.com/collections/best-sunscreen-for-acne-prone-skin | 5 | 5 | 3 |
https://shop.gangerdermatology.com/products/eltamd-uv-clear-broad-spectrum-spf-46-sunscreen-untinted | 1 | 1 | 2 |
https://health.com/beauty/skincare/best-sunscreen-for-body | 26 | 24 | 2 |
https://nbcnews.com/select/shopping/best-sunscreen-acne-rcna203278 | 8 | 8 | 2 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
The cited pages selected for review range from general dermatology guidance to shopping roundups and retailer listings. Several carry more than one conflicting claim, which makes them sensible starting points for a source review. A page linked to a claim is not necessarily its cause, and its current contents still need checking.
We would review each page against current primary sources before deciding whether any request is justified. Where a page appears accurate, the outcome is a no-change decision recorded for the client. Where it appears outdated, we would prepare an evidence-backed request that states the specific point and the supporting source.
This keeps outreach factual and modest. Publisher control is never assumed, and responses are logged separately from requests so the client can see what was asked versus what changed.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed EltaMD website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://eltamd.com/products/uv-clear-broad-spectrum-spf-46 | 3 | 3 | 3 |
https://eltamd.com/products/uv-clear-broad-spectrum-spf-46?hl=en-US | 2 | 2 | 2 |
https://eltamd.com/ | 1 | 1 | 0 |
https://eltamd.com/collections/acne-prone/products/uv-clear-broad-spectrum-spf-46?bvstate=pg%3A27%2Fct%3Ar | 1 | 0 | 0 |
https://eltamd.com/collections/rosacea-prone | 1 | 1 | 1 |
https://eltamd.com/collections/sun-care/oil-free | 1 | 1 | 1 |
https://eltamd.com/pages/authorized-reseller | 1 | 1 | 0 |
https://eltamd.com/products/eltamd-am-restore-moisturizer?_gsid=RjdMpGFub65H&variant=43509457027225 | 1 | 1 | 1 |
The company's website was cited 29 times across 26 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
The company's own site was cited across a wide spread of addresses, with the UV Clear product page appearing most often among those selected for review. Several other pages, including collection and reseller pages, were cited only occasionally. A citation does not by itself show that a page shaped a recommendation.
We would prepare page briefs for the priority addresses using approved facts, the buyer questions observed in the research, and clear product naming. The briefs would specify what the page should state, not rewrite it blindly, and would be checked against the live page before any change is proposed.
Because the cited addresses include duplicates and tracking variants, part of the work is simply consolidating the picture so the client knows which pages genuinely matter.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for EltaMD?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
What brand of sunscreen is best? | 4 | 4 | 4 |
What brand of sunscreen is the best? | 4 | 4 | 4 |
Which brands of sunscreen are best? | 4 | 4 | 4 |
Which is the best sunscreen for your face? | 4 | 4 | 4 |
Which sunscreen is best for acne-prone skin? | 4 | 4 | 4 |
Is there a non comedogenic sunscreen for acne? | 3 | 3 | 3 |
What are the 10 best sunscreens? | 3 | 3 | 3 |
What are the top 5 sunscreen brands? | 3 | 3 | 3 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The observed questions are broad brand and category queries, such as which sunscreen brand is best and which product suits acne-prone or facial use. EltaMD was mentioned and endorsed in every recorded answer to these questions, which suggests the brand is already part of the shortlist conversation rather than absent from it.
These are answer observations, not search volume or proof that the website lacks content. Before proposing anything new, we would check whether existing pages already answer each question well.
Where coverage is thin, the proposed work is buyer-question content briefs: plain comparisons, suitability guidance and clear product naming that give answers reliable material to draw on. Where coverage is already strong, the brief becomes a refresh rather than a new page.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed EltaMD work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the working base: a baseline scorecard, a scoped fact-review list and a shortlist of pages and sources to examine. Each record gets an owner, the evidence required and a review status, so nothing sits unresolved without a named next step.
The second month turns verified facts into approved page briefs and, where justified, publisher requests. Confirmed edits, no-change decisions, requests and responses are tracked separately, because a request is not an outcome.
The third month adds buyer-question content briefs and a fresh scorecard. Completed work is reported separately from measured answer outcomes, and any comparison carries its comparability limits. We would not present delivered work as proof of improved visibility.
Methodology
Questions This Section Answers
- How are EltaMD answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 368 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 5744 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Nov 2026 | 368 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.
Future editions using the same screening scope can be compared against this baseline.
The answers behind this report were collected for the stated month, though exact collection dates are unverified. Visibility rates rest on the answers that met the benchmark's inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording. Placement counts sit inside recommendations rather than adding to them.
Answers can mention several companies, so company counts do not sum to a number of distinct answers. Sentiment describes answer wording, not customer satisfaction. The citation analysis covers a wider set of captured answers than the benchmark, and cited pages still need independent checking.
Earlier editions used a narrower question set, so this edition is a new baseline. Future editions on the same scope can be compared against it.
Our first three priorities
First, verify the disputed price and SPF claims against current primary sources before any correction is considered. The highest-severity items around the UV Clear and UV Sport lines should be settled first, with the verified position and its date recorded. Ambiguous matches stay out of the queue.
Second, prepare page briefs for the priority company pages, led by the UV Clear product page, using approved facts and the buyer questions observed in the research. Check the live page first so the brief reflects what is actually there.
Third, review the most-cited external pages and prepare evidence-backed requests only where a specific point can be supported. Alongside this, draft buyer-question content briefs where existing coverage is thin. All of this is proposed work; none of it guarantees a change in measured visibility.
Related research
This report supports CiteWorks Studio's examination of how AI search is recommending Sunscreen Brands. For more detail, you can also read Sunscreen Brands: AI Visibility Discovery Index.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


